Research Output per year
Fingerprint Dive into the research topics where Mariangela Figini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 13 Similar Profiles
Folic Acid
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Antibodies
Medicine & Life Sciences
Folate Receptor 1
Medicine & Life Sciences
Antigen Receptors
Medicine & Life Sciences
Monoclonal Antibodies
Medicine & Life Sciences
Ovarian Neoplasms
Medicine & Life Sciences
Single-Chain Antibodies
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1992 2019
A bispecific antibody to link a trail-based antitumor approach to immunotherapy
Satta, A., Grazia, G., Caroli, F., Frigerio, B., Di Nicola, M., Raspagliesi, F., Mezzanzanica, D., Zaffaroni, N., Gianni, A. M., Anichini, A. & Figini, M., Jan 1 2019, In : Frontiers in Immunology. 10, OCT, 2514.Research output: Contribution to journal › Article
Open Access
Bispecific Antibodies
Immunotherapy
T-Lymphocytes
Neoplasm Antigens
TNF-Related Apoptosis-Inducing Ligand Receptors
Anti-PSMA 124I-scFvD2B as a new immuno-PET tool for prostate cancer: Preclinical proof of principle
Frigerio, B., Morlino, S., Luison, E., Seregni, E., Lorenzoni, A., Satta, A., Valdagni, R., Bogni, A., Chiesa, C., Mira, M., Canevari, S., Alessi, A. & Figini, M., Jul 23 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 326.Research output: Contribution to journal › Article
Open Access
Prostatic Neoplasms
Radiopharmaceuticals
Neoplasms
human glutamate carboxypeptidase II
Sensitivity and Specificity
Folate receptors and transporters: Biological role and diagnostic/therapeutic targets in cancer and other diseases
Frigerio, B., Bizzoni, C., Jansen, G., Leamon, C. P., Peters, G. J., Low, P. S., Matherly, L. H. & Figini, M., Mar 12 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 125.Research output: Contribution to journal › Article
Open Access
Folic Acid Transporters
Carbon
Folic Acid
Folate Receptor 2
Neoplasms
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE
Josephs, D. H., Nakamura, M., Bax, H. J., Dodev, T. S., Muirhead, G., Saul, L., Karagiannis, P., Ilieva, K. M., Crescioli, S., Gazinska, P., Woodman, N., Lombardelli, C., Kareemaghay, S., Selkirk, C., Lentfer, H., Barton, C., Canevari, S., Figini, M., Downes, N., Dombrowicz, D. & 8 others, , Dec 2018, In : Allergy: European Journal of Allergy and Clinical Immunology. 73, 12, p. 2328-2341 14 p.Research output: Contribution to journal › Article
Immunoglobulin E
Rodentia
Safety
Neoplasms
Therapeutics
Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer
Cheung, A., Opzoomer, J., Ilieva, K. M., Gazinska, P., Hoffmann, R. M., Mirza, H., Marlow, R., Francesch-Domenech, E., Fittall, M., Dominguez Rodriguez, D., Clifford, A., Badder, L., Patel, N., Mele, S., Pellizzari, G., Bax, H. J., Crescioli, S., Petranyi, G., Larcombe-Young, D., Josephs, D. H. & 9 others, , Oct 15 2018, In : Clinical Cancer Research. 24, 20, p. 5098-5111 14 p.Research output: Contribution to journal › Article
Folate Receptor 1
Triple Negative Breast Neoplasms
Antibodies
Growth
Heterografts